JP2024523884A5 - - Google Patents

Info

Publication number
JP2024523884A5
JP2024523884A5 JP2023577510A JP2023577510A JP2024523884A5 JP 2024523884 A5 JP2024523884 A5 JP 2024523884A5 JP 2023577510 A JP2023577510 A JP 2023577510A JP 2023577510 A JP2023577510 A JP 2023577510A JP 2024523884 A5 JP2024523884 A5 JP 2024523884A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
labeled
radiolabeled compound
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023577510A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523884A (ja
Filing date
Publication date
Priority claimed from GBGB2108608.7A external-priority patent/GB202108608D0/en
Application filed filed Critical
Publication of JP2024523884A publication Critical patent/JP2024523884A/ja
Publication of JP2024523884A5 publication Critical patent/JP2024523884A5/ja
Pending legal-status Critical Current

Links

JP2023577510A 2021-06-16 2022-06-16 ｐＨ調整されたアスコルビン酸溶液の調製 Pending JP2024523884A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2108608.7A GB202108608D0 (en) 2021-06-16 2021-06-16 Preparation of a ph-adjusted ascorbic acid solution
GB2108608.7 2021-06-16
PCT/EP2022/066481 WO2022263592A1 (en) 2021-06-16 2022-06-16 Preparation of a ph-adjusted ascorbic acid solution

Publications (2)

Publication Number Publication Date
JP2024523884A JP2024523884A (ja) 2024-07-02
JP2024523884A5 true JP2024523884A5 (enExample) 2025-06-11

Family

ID=76954449

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023577510A Pending JP2024523884A (ja) 2021-06-16 2022-06-16 ｐＨ調整されたアスコルビン酸溶液の調製

Country Status (6)

Country Link
US (1) US20240350683A1 (enExample)
EP (1) EP4355368A1 (enExample)
JP (1) JP2024523884A (enExample)
CN (1) CN117500525A (enExample)
GB (1) GB202108608D0 (enExample)
WO (1) WO2022263592A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0520527D0 (en) 2005-10-10 2005-11-16 Ge Healthcare Ltd Automated method
KR20160030589A (ko) * 2009-04-15 2016-03-18 랜티우스 메디컬 이메징, 인크. 아스코르브산을 사용한 방사성 약제 조성물의 안정화
DK3323810T3 (da) 2010-02-08 2022-03-28 Lantheus Medical Imaging Inc Automatiseret reaktionssystem, kassette og indretning til syntese af billeddannelsesmidler
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer

Similar Documents

Publication Publication Date Title
AU2016201367B2 (en) Stabilization of radiopharmaceutical compositions using ascorbic acid
CA1177091A (en) Cationic lipophilic complexes of 99m tc and their use for myocardial and hepatobiliary imaging
EP0031121B1 (en) Method, composition and kit for stabilizing radiolabeled compounds
CN104470547B (zh) 利用筒状物合成放射性药物的方法
Molavipordanjani et al. Basic and practical concepts of radiopharmaceutical purification methods
Haveman et al. State of the art procedures towards reactive [18F] fluoride in PET tracer synthesis
JP2024523884A5 (enExample)
US8968701B2 (en) Usage of low to medium-pressure liquid chromatography for the purification of radiotracers
JPS645256B2 (enExample)
Loc'h et al. Preparation of [76Br] FLB 457 and [76Br] FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET
JP2024518319A5 (enExample)
Käkelä et al. Adventures in radiosynthesis of clinical grade [68 Ga] Ga-DOTA-Siglec-9
US20200047158A1 (en) Solid phase conditioning
JP2024522770A5 (enExample)
CN117500525A (zh) pH调节的抗坏血酸溶液的制备
Ryzhikov et al. Preparation of [18F] flumazenil, a potential radioligand for PET imaging of central benzodiazepine receptors, by isotope exchange
US5738836A (en) Composition for stabilizing radiolabeled organic compounds
WO2009029633A1 (en) Synthesis of [18f]-labelled alkyl mesylates using fluorous spe separation
US12312653B2 (en) Systems and methods for generating lead
PT1797022E (pt) Métodos para a purificação de produtos marcados radioactivamente utilizando um captador em suporte sólido
Welch et al. Potential labeling of monoclonal antibodies with positron emitters
Pfeiffer Quality Control of Radiopharmaceuticals: Recent Developments in Analytical Techniques
RU2760273C1 (ru) Способ получения комплексов на основе изотопа галлий-68
Jeffries Nonisotopic Labeling
Lamesa et al. 68Ga somatostatin analog radiolabelling: The radiopharmacist's point of view